William J Placzek

researcher

William J Placzek is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID0722303523.70
P496ORCID iD0000-0003-4096-8617
P10861Springer Nature person ID0722303523.70

P69educated atWashington University in St. LouisQ777403
Scripps ResearchQ793867
Sanford Burnham Prebys Medical Discovery InstituteQ7417591
P108employerUniversity of Alabama at BirminghamQ1472663
P735given nameWilliamQ12344159
WilliamQ12344159
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q6486379614-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein
Q100737086A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma
Q33833506A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
Q39614305An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins
Q40886681BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Q27646917Cold-adaptation in sea-water-borne signal proteins: sequence and NMR structure of the pheromone En-6 from the Antarctic ciliate Euplotes nobilii
Q46155919Cold-adapted signal proteins: NMR structures of pheromones from the Antarctic ciliate Euplotes nobilii
Q34033295Identification of a novel Mcl-1 protein binding motif
Q89947517MCL1 binding to the reverse BH3 motif of P18INK4C couples cell survival to cell proliferation
Q101216832MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73
Q46053861NMR assignment of a human cancer-related nucleoside triphosphatase
Q27643786NMR structure and functional characterization of a human cancer-related nucleoside triphosphatase
Q89759447Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer
Q39397346Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells.
Q41636962PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics
Q47716556Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members
Q65001761Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents.
Q36172754Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer
Q48258967Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
Q34686567Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins
Q94461258The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of alpha-synuclein
Q90687634UBC9 Mutant Reveals the Impact of Protein Dynamics on Substrate Selectivity and SUMO Chain Linkages
Q48473046Volatile anesthetics bind rat synaptic snare proteins

Search more.